MetaCap

Nuvation Bio (NUVB) Stock Chart

NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.80-0.01 (-0.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NUVB technical summary

NUVB is trading 21.9% below its 50-day simple moving average of $4.87 and 28.0% below its 200-day average of $5.28. The 50-day average is below the 200-day average, a crossover (often called a "death cross") that occurred within the last month. The 14-day Relative Strength Index (RSI) is 31.0, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $3.71 (Nov 19, 2026) to $9.75 (Dec 22, 2025); the current price sits 1% of the way from the low to the high. Annualized 30-day volatility is 57.5%. Based on the last session's high, low and close, the classic pivot point is $3.81, with first resistance at $3.90 and first support at $3.71.

These indicators describe past price behavior for Nuvation Bio; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
9.75 (Dec 22)
1Y low
3.71 (Nov 19)
Last close
3.80

NUVB price performance

1 week

-4.76%

1 month

-21.65%

3 months

-45.17%

6 months

-19.49%

Year to date

-57.59%

1 year

-45.64%

3 years

+192.31%

5 years

-53.49%

NUVB price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day3.83Price below3.86Price below
10-day4.00Price below3.99Price below
20-day4.28Price below4.22Price below
50-day4.87Price below4.78Price below
100-day5.64Price below5.21Price below
200-day5.28Price below5.49Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)4.09
Resistance 2 (R2)4.00
Resistance 1 (R1)3.90
Pivot point3.81
Support 1 (S1)3.71
Support 2 (S2)3.62
Support 3 (S3)3.52

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis